[1]Division of Nephrology Department of Internal Medicine Dalin Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation Chiayi County 622 Taiwan;
[2]School of Medicine Tzu Chi University Hualien 970 Taiwan;
[3]Department and Graduate Institute of Public Health College of Medicine National Cheng Kung University Tainan 701 Taiwan;
[4]Department of Public Health College of Public Health China Medical University Taichung 404 Taiwan;
[5]Department of Medical Research Dalin Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation Chiayi County 622 Taiwan;
[6]Division of Hepato-Gastroenterology Department of Internal Medicine Dalin Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation Chiayi County 622 Taiwan;
Hepatitis C virus; Chronic kidney disease; End-stage renal disease; Antihepatitis C virus therapy; Cohort study;